Just a few months after she was diagnosed with acute lymphoblastic leukemia (ALL) Laura Bray’s daughter Abby, then nine, encountered her first drug shortage.
Abby was among the 20% of ALL patients who develop allergies to E-coli-based enzymes used in the normally curative standard...